Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 1.22
SYK's Cash to Debt is ranked higher than
65% of the 513 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. SYK: 1.22 )
SYK' s 10-Year Cash to Debt Range
Min: 0.04   Max: 164.16
Current: 1.22

0.04
164.16
Equity to Asset 0.50
SYK's Equity to Asset is ranked higher than
58% of the 480 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. SYK: 0.50 )
SYK' s 10-Year Equity to Asset Range
Min: 0.22   Max: 0.78
Current: 0.5

0.22
0.78
F-Score: 3
Z-Score: 4.41
M-Score: -2.81
WACC vs ROIC
10.69%
9.13%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 15.60
SYK's Operating margin (%) is ranked higher than
90% of the 488 Companies
in the Global Medical Devices industry.

( Industry Median: 4.77 vs. SYK: 15.60 )
SYK' s 10-Year Operating margin (%) Range
Min: -5.63   Max: 23.92
Current: 15.6

-5.63
23.92
Net-margin (%) 6.86
SYK's Net-margin (%) is ranked higher than
81% of the 488 Companies
in the Global Medical Devices industry.

( Industry Median: 3.24 vs. SYK: 6.86 )
SYK' s 10-Year Net-margin (%) Range
Min: 0.92   Max: 17.39
Current: 6.86

0.92
17.39
ROE (%) 7.67
SYK's ROE (%) is ranked higher than
79% of the 479 Companies
in the Global Medical Devices industry.

( Industry Median: 4.18 vs. SYK: 7.67 )
SYK' s 10-Year ROE (%) Range
Min: 2.89   Max: 28.97
Current: 7.67

2.89
28.97
ROA (%) 3.93
SYK's ROA (%) is ranked higher than
79% of the 516 Companies
in the Global Medical Devices industry.

( Industry Median: 1.45 vs. SYK: 3.93 )
SYK' s 10-Year ROA (%) Range
Min: 0.71   Max: 15.38
Current: 3.93

0.71
15.38
ROC (Joel Greenblatt) (%) 64.30
SYK's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 512 Companies
in the Global Medical Devices industry.

( Industry Median: 5.87 vs. SYK: 64.30 )
SYK' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -12.96   Max: 71.6
Current: 64.3

-12.96
71.6
Revenue Growth (3Y)(%) 5.80
SYK's Revenue Growth (3Y)(%) is ranked higher than
79% of the 348 Companies
in the Global Medical Devices industry.

( Industry Median: 4.50 vs. SYK: 5.80 )
SYK' s 10-Year Revenue Growth (3Y)(%) Range
Min: 5.8   Max: 32.9
Current: 5.8

5.8
32.9
EBITDA Growth (3Y)(%) -5.70
SYK's EBITDA Growth (3Y)(%) is ranked higher than
70% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 1.90 vs. SYK: -5.70 )
SYK' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -9.6   Max: 59.4
Current: -5.7

-9.6
59.4
EPS Growth (3Y)(%) -26.90
SYK's EPS Growth (3Y)(%) is ranked higher than
60% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 0.50 vs. SYK: -26.90 )
SYK' s 10-Year EPS Growth (3Y)(%) Range
Min: -43   Max: 153
Current: -26.9

-43
153
» SYK's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

SYK Guru Trades in Q2 2014

Mario Gabelli 20,100 sh (New)
Jim Simons 38,800 sh (New)
George Soros 1,678,108 sh (+52.75%)
Paul Tudor Jones 7,777 sh (+38.88%)
PRIMECAP Management 304,500 sh (unchged)
Vanguard Health Care Fund 1,433,500 sh (unchged)
Ray Dalio Sold Out
Joel Greenblatt Sold Out
Ken Fisher 3,320 sh (-2.64%)
Robert Olstein 98,000 sh (-5.77%)
Yacktman Fund 4,613,000 sh (-5.86%)
Donald Yacktman 10,178,928 sh (-12.19%)
Chuck Royce 92,000 sh (-12.21%)
Jeremy Grantham 2,047,202 sh (-17.21%)
Yacktman Focused Fund 3,830,000 sh (-20.21%)
» More
Q3 2014

SYK Guru Trades in Q3 2014

Ray Dalio 10,341 sh (New)
Dodge & Cox 4,170 sh (New)
Diamond Hill Capital 425,344 sh (New)
Paul Tudor Jones 80,548 sh (+935.72%)
Jim Simons 131,600 sh (+239.18%)
Ken Fisher 3,535 sh (+6.48%)
Jeremy Grantham 2,135,547 sh (+4.32%)
Robert Olstein 98,000 sh (unchged)
PRIMECAP Management 304,500 sh (unchged)
Vanguard Health Care Fund 1,433,500 sh (unchged)
Mario Gabelli 20,100 sh (unchged)
Yacktman Fund 4,400,000 sh (-4.62%)
Donald Yacktman 9,596,895 sh (-5.72%)
Yacktman Focused Fund 3,500,000 sh (-8.62%)
George Soros 1,368,566 sh (-18.45%)
Chuck Royce 72,200 sh (-21.52%)
» More
Q4 2014

SYK Guru Trades in Q4 2014

Diamond Hill Capital 1,001,380 sh (+135.43%)
Ray Dalio 11,841 sh (+14.51%)
Jeremy Grantham 2,262,681 sh (+5.95%)
PRIMECAP Management 304,500 sh (unchged)
Vanguard Health Care Fund 1,433,500 sh (unchged)
Mario Gabelli Sold Out
George Soros Sold Out
Chuck Royce Sold Out
Jim Simons Sold Out
Ken Fisher 3,366 sh (-4.78%)
Dodge & Cox 3,360 sh (-19.42%)
Yacktman Fund 3,435,000 sh (-21.93%)
Yacktman Focused Fund 2,717,000 sh (-22.37%)
Donald Yacktman 7,334,707 sh (-23.57%)
Robert Olstein 73,000 sh (-25.51%)
Paul Tudor Jones 3,000 sh (-96.28%)
» More
Q1 2015

SYK Guru Trades in Q1 2015

Vanguard Health Care Fund 1,433,500 sh (unchged)
Ken Fisher 3,320 sh (-1.37%)
Yacktman Fund 3,050,000 sh (-11.21%)
Donald Yacktman 6,365,465 sh (-13.21%)
Yacktman Focused Fund 2,300,000 sh (-15.35%)
» More
» Details

Insider Trades

Latest Guru Trades with SYK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK